e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
MS6 Community-acquired pneumonia: moving from guidelines to clinical practice
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of guidelines in the outcomes of CAP: the evidence
A. Torres (Barcelona, Spain)
Source:
Annual Congress 2013 –MS6 Community-acquired pneumonia: moving from guidelines to clinical practice
Session:
MS6 Community-acquired pneumonia: moving from guidelines to clinical practice
Session type:
Morning Seminar
Number:
3265
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Torres (Barcelona, Spain). Impact of guidelines in the outcomes of CAP: the evidence. Annual Congress 2013 –MS6 Community-acquired pneumonia: moving from guidelines to clinical practice
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Navin Mishra - 28.01.2017 10:06
good
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Describing what evidence and outcomes to use in guidelines
Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD
Year: 2008
Assessment of asthma control based on French guidelines criteria. Results from a pharmacy-based study
Source: Eur Respir J 2006; 28: Suppl. 50, 684s
Year: 2006
Adaptation rate between COPD treatment in clinical practice and guidelines recommendations
Source: Eur Respir J 2007; 30: Suppl. 51, 779s
Year: 2007
Assessment of efficacy of pulmonary rehabilitation: which outcomes do we need to focus on?
Source: ERS Course 2017
Year: 2017
Determinants of long-term changes in ADO prognostic score in UK COPD primary care patients: results from The Health Improvement Network
Source: International Congress 2019 – Powerful cohort studies with/without lung function
Year: 2019
Guidelines versus clinical practice in the treatment of COPD: a reappraisal
Source: Eur Respir J 2006; 27: 656
Year: 2006
Community acquired pneumonia guidelines: not only treatment indications
Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis
Year: 2004
Implementing an evidence based protocol in ICU: Physiotherapists’ perceptions
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2
Year: 2020
Patient and public involvement in guidelines and its impact on quality improvement
Source: Annual Congress 2013 –ELF/ERS “Effective engagement of patients and the public in science, healthcare and the media”
Year: 2013
Management of COPD in primary care: an audit of NICE guidance and cost effectiveness
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017
Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
ERS guidelines: treatment options and recommendations
Source: International Congress 2019 – Guidelines for long-term non-invasive ventilation in chronic obstructive pulmonary disease
Year: 2019
Global asthma physician & patient (GAPP) survey: differences between treatment practice and GINA guideline recommendations in Europe – paediatric findings
Source: Eur Respir J 2006; 28: Suppl. 50, 480s
Year: 2006
Comment on: International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Source: Eur Respir J 2014; 44: 266
Year: 2014
Comment on: International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Source: Eur Respir J 2014; 44: 267-268
Year: 2014
Comment on: International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Source: Eur Respir J 2014; 44: 267
Year: 2014
The WHO Guidelines for the Programmatic Management of drug-resistant TB: the 2011 update - recommendations and evidence
Source: Annual Congress 2011 - ECDC and WHO tuberculosis guidelines: update 2011 (organised within the FP7 funded TB-PAN-NET project)
Year: 2011
Asthma treatment impacts time to pregnancy: evidence from the international SCOPE study
Source: Eur Respir J, 51 (2) 1702035; 10.1183/13993003.02035-2017
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept